MXPA06003464A - Cosmetic deodorant composition comprising a combination of zinc salicylate or a derivative thereof with an aluminium salt antiperspirant active - Google Patents

Abstract

The present invention is related to a cosmetic deodorant composition, which comprises at least:a) zinc salicylate or a derivative thereof, and b) an antiperspirant aluminum salt, where the zinc salicylate and the aluminum salt are present in a weight ratio of from about 1:500 to about 10:1, and preferably from about 1:200 to about 1:1. The invention further refers to a cosmetic process for treating human perspiration and human axillary odours by using the present composition.

Description

DEODORANT COSMETIC COMPOSITION COMPRISING THE ASSOCIATION OF ZINC SALICILATE OR ONE OF ITS DERIVATIVES AND A SALT OF ANTI-TRANSPIRANT ALUMINUM.

DESCRIPTION OF THE INVENTION The invention has for its object a deodorant cosmetic composition comprising at least: a) zinc salicylate or one of its derivatives, in free or hydrated form and b) at least one anti-perspirant aluminum salt; the weight ratio zinc salicylate / aluminum salt oscillating between 1/500 and 10/1 and preferably between 1/200 and 1/1. The invention also relates to a method of cosmetic treatment of human perspiration and human axillary odors with the aid of this composition. The invention relates to the use of the combination of zinc salicylate or one of its derivatives and of an antiperspirant aluminum salt as an active deodorant in a cosmetic composition. In the cosmetic field, it is well known to use topical application deodorants containing active substances of the antiperspirant type of bactericidal or odor-absorbing type to reduce, Ref. 169061 even suppress, usually unpleasant axillary odors. Bactericidal substances inhibit the development of the cutaneous flora responsible for axillary odors. They have the disadvantage of not being active on the smell of sweat already developed. Among the bactericidal products, the most commonly used is Triclosan (2,4,4'-trichloro-2'-hydroxydiphenyl ether), which has the disadvantage of significantly modifying the ecology of the cutaneous flora, of being inhibited by certain compounds , such as, for example, nonionic surfactants, currently used in the formulation of cosmetic compositions. On the other hand, the insoluble nature of Triclosan in water does not allow its incorporation into essentially aqueous formulas. The anti-perspirant substances have the effect of limiting the sudoral flow. They are generally constituted by aluminum salts. Its deodorant effectiveness is limited when used alone. In addition, at high concentrations, these substances have a potential irritant to the skin. Among the deodorant active agents, some water-soluble zinc salts have already been proposed in deodorant products such as, for example, zinc pyrrolidone carboxylate (more commonly known as sodium pidolate). zinc), zinc sulfate, zinc chloride, zinc lactate, zinc gluconate and zinc phenolsulfonate. Such deodorant formulations have been particularly described in documents 093/01793, EP468564, EP024176 and EP768080. In the 1930s as described in particular the work Drugs & Cosmetic lndustry-Modern Cosmetics; Chapter Deodorants pages 168-177 (1934), it was known that zinc salicylate could be formulated in paste-type deodorant or bar-form formulations in the necessary presence of other active agents for sufficient deodorant action. It has been proposed more recently as a possible deodorant active agent in different supports, according to the patent EP318206 in bar gels based on becilidene sorbitol, an emollient of the di-isopropyladipate type, one or more polar solvents and a coupling agent; according to patents US 5,254,332 and US 5,302,381 in bars containing a volatile silicone oil, a low melting point wax, an emollient insoluble in liquid water and in the presence of a deodorant active agent of the sodium bicarbonate type; according to application 002/1 3776 in aqueous gels based on fatty acid soaps. However, the effectiveness of its zinc salts is limited when used alone. To allow to increase the deodorant efficiency, Different associations of active agents have been proposed. In patent application 097/24131, it has been proposed to associate zinc salicylate with an acylglycine US Pat. No. 6,426,061 also known compositions for combating the development of human skin perspiration odors comprising the association of the following active agents: (1) an androgen receptor inhibitor (resveratrol, epigallocatechin-3-) gallate or flufenamic acid); (2) an active anti-DHT agent (zinc salts in particular zinc sulfate) (3) an inhibitor of odor-carrying proteins, (4) an anti-perspirant aluminum salt and (5) an antimicrobial agent of the type chlorhexidine digluconate or chlorhexidine diacetate. These compositions have the disadvantage of using particularly active antimicrobial agents on the cutaneous flora. It is known from patent application O01 / 52804 deodorant compositions based on antiperspirant salts to which it is proposed to add transition metal chelators (DPTA). These formulations are potentially ecotoxic. In the patent application EP1486199, alcohol-based aerosol compositions have been described. zinc salicylate or one of its derivatives. Although it is generally described, in this application, the possibility of associating antiperspirant salts, the applicant has observed that in particular relative amounts the deodorant efficacy obtained was insufficient. The object of the present invention is therefore to have new cosmetic compositions comprising a deodorant system with an efficiency superior to that of the anti-perspirant salts and that of the zinc salicylate salts used alone and which do not have the disadvantages of the same. deodorant products of the prior art as mentioned above. The Applicant has discovered that a composition of this type was obtained using the association of zinc salicylate or one of its derivatives and of an anti-perspirant aluminum salt in a weight ratio zinc salicylate / aluminum salt ranging from 1 / 500 and 10/1 and preferably between 1/200 and 1/1. The applicant firm has unexpectedly discovered that this particular association had a synergistic effect at the level of the decrease in odor intensity in relation to the active agents used individually. More specifically, the invention relates to a deodorant cosmetic composition comprising at least: a) zinc salicylate or one of its derivatives, in free or hydrated form and b) at least one anti-perspirant aluminum salt; the weight ratio zinc salicylate / aluminum salt oscillating between 1/500 and 10/1 and preferably between 1/200 and 1/1. The invention also relates to a method of cosmetic treatment of human perspiration and human axillary odors with the aid of this composition. The invention relates to the use of the association of zinc salicylate or one of its derivatives and of an antiperspirant aluminum salt as deodorant active agent in a cosmetic composition; in a weight ratio zinc salicylate / aluminum salt ranging between 1/500 and 10/1 and preferably between 1/200 and l / l. In the sense of the present invention, "deodorant composition" is understood to mean any composition capable of reducing sudoral flow, hiding, absorbing, improving and / or reducing the unpleasant odor resulting from the decomposition of human sweat by bacteria. "Anti-perspirant aluminum salt" means any salt or aluminum complex that has the effect of reducing or limiting the sudoral flow. The aluminum salts according to the invention are preferably chosen from aluminum halohydrates; the aluminum and zirconium halohydrates, the zirconium hydroxychloride and aluminum hydroxychloride complexes with or without an amino acid such as those described in US Pat. No. 3,798,2068. Among the aluminum salts, mention may be made in particular of aluminum chlorohydrate in activated or non-activated form, aluminum chlorohydrex, aluminum complex chlorhydrex polyethylene glycol, aluminum complex hydrochloride propylene glycol, aluminum dichlorohydrate, aluminum complex dichlorhydrex polyethylene glycol , the aluminum complex dichlorhydrex propylene glycol, the aluminum sesquichlorhydrate, the aluminum complex sesquiclorhidrex polyethylene glycol, the aluminum complex sesquiclorhidrex propilenglicol, the aluminum sulfate buffered by sodium lactate and aluminum. Among the aluminum and zirconium salts, mention may be made in particular of aluminum zirconium octahydrochloride, aluminum zirconium pentachlorhydrate, aluminum zirconium tetrahydrochloride, aluminum zirconium trichlorohydrate. Complexes of zirconium hydroxychloride and aluminum hydroxychloride with an amino acid are generally known under the name ZAG (when the amino acid is glycine). Among these products we can mention the complexes of aluminum zirconium octachlorhydrex glycine, aluminum zirconium pentachlorhydrex glycine, aluminum zirconium tetrachlorhydrex glycine and aluminum zirconium trichlorhydrex glycine. Aluminum hydrochloride in activated or non-activated form will be used more particularly. The antiperspirant aluminum salts may be present in the composition according to the invention in a proportion of about 0.5 to 25% by weight relative to the total weight of the composition. The zinc salicylate and its derivatives according to the invention respond in general to the following structure: wherein n = 2, p equals 0, 1, 2 or 3; Ri denotes a linear or branched CX-L alkyl (for example methyl, ethyl, n-propyl, isopropyl, n-butyl); a hydroxyalkyl radical of C_-C _, linear or branched; a halogen atom (for example iodine, bromine, chlorine); a C2-C18 acyl radical (for example acetyl); a radical COR2, OCOR2 or C0NHR2 where R2 denotes a hydrogen atom or a linear or branched C? -C? 8 alkenyl radical. More preferably, zinc salicylate (p = 0) and more particularly in hydrated form such as zinc salicylate trihydrate such as the commercial product sold under Zinc Salicylate Trihydrate "will be chosen.

Bernardy Chimie Society. In the compositions of the invention, the concentration in zinc salicylate varies preferably from 0. 001 to 20%, more preferably 0.01 to 15% and even more preferably 0.05 to 5% by weight relative to the total weight of the composition. The deodorant compositions according to the invention intended for cosmetic use can be presented in the form of lotions, creams or fluid gels distributed in an aerosol spray, in an atomizer or in a roll-on, in the form of thick creams distributed in tubes or in a grid; in the form of bars (sticks), and contain in this respect the ingredients generally used in this type of products and well known to the person skilled in the art, with the proviso that they do not interfere with the aluminum salt and the zinc salicylate described in the present invention. Preferably, it will be avoided to condition the compositions according to the invention in an alcoholic aerosol device insofar as the aluminum salt / C_-C4 alcohol / aerosol conditioning mixture has a tendency to cause either degradation of the composition or corrosion of the composition. the aerosol containers, or a loss of effectiveness of the antiperspirant active agent. According to a preferential form, the composition is different from an alcoholic aerosol composition.

By "alcohol aerosol composition" is meant any formulation comprising at least one propellant and at least one mono-C 4 -C alcohol such as propanol, ethanol or isopropanol. The deodorant compositions according to the invention intended for cosmetic use may comprise at least one aqueous phase. They are particularly formulated in aqueous lotions or water-in-oil, oil-in-water, or multiple emulsion emulsions (oil-in-water-in-oil or water-in-oil-in-water emulsion) emulsions are known and described for example by C. FOX in "Cosmetics and Toiletries" - November 1986 - Vol 101 - pages 101-112.) The aqueous phase of the said compositions contains water and in general other solvents soluble or miscible in water. Water-soluble or water-miscible solvents comprise short-chain monohydric alcohols, for example C4-C4 such as ethanol, isopropanol, diols or polyols such as ethylene glycol, 1,2-propylene glycol, 1,3-butylene glycol. , hexylene glycol, diethylene glycol, dipropylene glycol, 2-ethoxyethanol, diethylene glycol monomethylether, triethylene glycol monomethyl ether and sorbitol, and propylene glycol and glycerin will be used more particularly, according to a particular form of the invention, Antiperspirants can be anhydrous.

By "anhydrous", it is understood in the sense of the invention, a composition whose content in free or added water is less than 3% and preferably whose added water content is less than 1% by weight with respect to the total weight of the water. The compositions according to the invention preferably comprise at least one organic liquid phase which is immiscible with water, it generally comprises one or more hydrophobic compounds which make the said phase water-immiscible, the indicated phase being liquid (in the absence of an agent). structuring) at room temperature (20-25 ° C) .Preferentially, the organic water-immiscible liquid organic phase according to the invention is generally constituted by an oil or mixture of oils and comprises at least 80% of compounds with a pressure vapor not exceeding 4 kPa (30 mm Hg) at 25 ° C. The organic liquid phase which is immiscible with water preferably contains one or more silicone or hydrocarbon emollients, volatile or non-volatile. These emollient oils are particularly described in US Patents 4,822,596 and 4,904,463. Volatile silicones are defined in a manner known as volatile compounds at room temperature. Mention may be made, among these compounds, of the cyclic and linear volatile silicones of the dimethylsiloxane type whose chains They comprise from 3 to 9 siliconized waste. Preferably cyclomethicones D, D5 or D are selected. Non-volatile silicones are defined in a known manner as low vapor pressure compounds at room temperature. These compounds include: polyalkylsiloxanes, in particular linear polyalkylsiloxanes, such as linear polydimethylsiloxanes, or dimethicones, marketed by the Dow Corning Company under the name "Dow Corning 245 Fluid"; polyalkylaryl siloxanes, such as, for example, polymethylphenylsiloxanes, marketed by the Dow Corning Company under the name "Dow Corning 556 Fluid"; polyether and siloxane copolymers, such as, for example, dimethicone copolyols. Among the non-volatile emollient oils which can be used in the present invention, there may be mentioned, for example: hydrocarbon derivatives, mineral oils, fatty alcohols, esters of C3-C_8 alcohols with C3-C18 acids, benzoic acid esters with C2-C18 alcohols and mixtures thereof, C2-C6 polyols selected preferably from glycerol, propylene glycol or sorbitol, polyalkylene glycol polymers. Emollient oils are preferably present in amounts ranging from 1 to 50% by weight and more preferably from 5 to 40% by weight relative to the total weight of the composition. The deodorant cosmetic composition according to the invention may contain one or more additional deodorant active agents such as for example bacteriostatic agents or bactericidal agents such as 2,4,4'-trichloro-2'-hydroxydiphenylether (Triclosan), 2,4-dichloro -2 '-hydroxydiphenylether, 3', 4 ', 5'-trichlorosalicylanilide, 1- (3', 4'-dichlorophenyl) -3- (4'-chlorophenyl) urea (Triclocarban) or 3, 7, ll -trimethyldodeca-2, 5, 10-trienol (Farnesol); quaternary ammonium salts such as cetyltrimethylammonium salts, cetylpyridinium salts; chlorhexidine and salts; the diglycerol monocaprate, the diglycerol monolaurate, the glycerol monolaurate; the polyhexamethylene biguanidine salts. In order to improve the homogeneity of the product, it is also possible to use one or more suspension agents which are preferably selected from hydrophobic modified montmorillonite clays such as bentonites or hydrophobic modified hectorites. Mention may be made, for example, of the product Stearalkonium Bentonite (name CTFA) (reaction product of bentonite and quaternary ammonium stearalkonium chloride) such as the commercial product sold under the name TIXOGEL MP 250 by the Sud Society CHEMIE Rheologicals, United Catalyts Inc or the product Disteardimonium Hectorite (name CTFA) (reaction product of hectorite and distearyldimonium chloride) sold under the name of Bentone 38 or Bentone Gel by the Elementies Specialties Company. The suspending agents are preferably present in amounts ranging between 0.1 and 5% by weight and more preferably between 0.2 and 2% by weight relative to the total weight of the composition. The compositions according to the invention can also contain at least one organic powder. Among the fillers which can be used according to the invention, organic powders can be mentioned. In the present application, the term "organic powder" means any solid insoluble in the medium at room temperature (25 ° C). As organic powders that can be used in the composition of the invention, mention may be made, for example, of the polyamide particles and particularly those sold under the names ORGASOL by the Atochem Company; polyethylene powders; microspheres based on acrylic copolymers, such as those of copolymer ethylene glycol dimethacrylate / lauryl methacrylate sold by the Dow Corning Company under the name of POLYTRAP; the polymethyl methacrylate microspheres, marketed under the name MICROSPHERE M-100 by the Matsumoto company or under the name COVABEAD LH85 by the Society ackherr; ethylene-acrylate copolymer powders, such as those marketed under the name FLOBEADS by the Company Suika Seika Chemicals; expanded powders such as hollow microspheres and in particular, microspheres formed by a terpolymer of vinylidene chloride, acrylonitrile and methacrylate and marketed under the name EXPANCEL by the company emanord Plast under references 551 DE 12 (granulometry of approximately 12 μm and mass volume 40 kg / m3), 551 DE 20 (granulometry of approximately 30 μm and density of 65 kg / m3), 551 DE 50 (granulometry of approximately 40 μm), or microspheres marketed under the name MICROPEARL F 80 ED by the Company Matsumoto; powders of natural organic materials such as starch powders, particularly corn, wheat or rice starches, crosslinked or not, such as starch powders crosslinked by octenyl succinate anhydride, marketed under the name DRY-FLO by the Company National Starch; silicone resin microbeads such as those marketed under the name TOSPEARL by the Toshiba Silicone Company, particularly TOSPEARL 240; amino acid powders such as the Lauroillisin powder marketed under the name AMIHOPE LL-11 by the Ajinomoto Society; the wax microdispersion particles, which preferably have lower average dimensions at 1 μm, and consisting essentially of a wax or a mixture of waxes, such as the products marketed under the name Aquacer by the Byk Cera Company, and in particular: Aquacer 520 (mixture of synthetic and natural waxes), Aquacer 514 or 513 (polyethylene wax), Aquacer 511 (polymer wax), or such as the products marketed under the name Jonwax 120 by the company Jonson Polymer (mixture of polyethylene and paraffin waxes) and under the name Ceraflour 961 by the Company Byk Wax (micronized modified polyethylene wax); and its mixtures. The cosmetic composition according to the invention may further comprise cosmetic adjuvants selected from waxes, softeners, antioxidants, opacifiers, stabilizers, moisturizing agents, vitamins, perfumes, bactericides, preservatives, polymers, perfumes, Thickening agents, propellants or any other ingredient commonly used in cosmetics for this type of application. Of course, the person skilled in the art will try to choose this or these possible complementary compounds in such a way that the advantageous properties intrinsically related to the cosmetic composition according to the invention are not, or substantially, altered by the addition (s) considered.

The waxes can be chosen from animal, fossil, vegetable, mineral or synthetic waxes. Mention may be made in particular of beeswax, Carnauba, Candelilla, sugarcane, Japan, ozokerite waxes, Montan wax, microcrystalline waxes, paraffins, waxes and silicone resins. The thickeners, preferably non-ionic, can be chosen from guar gums and modified or unmodified celluloses such as hydroxypropylated guar gum, cetylhydroxyethylcellulose, silicas such as Bentona Gel MIÓ sold by the NL INDUSTRIES Company or the Veegum Ultra, sold by the Society POLYPLASTIC. The amounts of these different constituents that may be present in the cosmetic composition according to the invention are those conventionally used in deodorant compositions. The compositions according to the invention may also contain one or more other structuring or gelling agents of the water-immiscible organic liquid phase of the composition, such as linear solid fatty alcohols and / or waxes; fatty acids or their salts (stearic acid, sodium stearate, 12-hydroxystearic acid); the dibenzylidene alditols (DBS); lanosterol, the N-acyl amino acid derivatives; the derivatives of di or triacidos carboxylics such as alkyl N, N '-dialkylsuccinamides (ie: dodecyl N, N'-dibutylsuccinamide); the organopolysiloxane elastomers such as those described in the application 097/44010. The composition according to the invention can also be pressurized and conditioned in an aerosol device. The present invention relates to an aerosol device consisting of: (A) a container comprising a deodorant composition as defined above, (B) at least one propellant and a means of distributing said aerosol composition. The propellants generally used in this type of products and well known to those skilled in the art are, for example, dimethyl ether (DME); volatile hydrocarbons such as n-butane, propane, isobutane, and mixtures thereof, optionally with at least one gold and / or fluorinated hydrocarbon; among the latter, mention may be made of the compounds sold by the Dupont de Nemours Company under the names Fréon® and Dymel®, and in particular monofluorotrichloromethane, difluorodichloromethane, tetrafluorodichloroethane and 1,1-difluoroethane, sold in particular under the trade name DYM? L 152 A by the DUPONT Company. It can also be used as propellant agent carbon dioxide, nitrous oxide, nitrogen or compressed air. The composition containing the deodorant active agent (s) and the propellant (s) may be in the same compartment or in different compartments in the aerosol container. According to the invention, the concentration in propellant agent generally ranges from 5 to 95% by weight pressurized and more preferably from 50 to 85% by weight relative to the total weight of the pressurized composition. The distribution means, which forms a part of the aerosol device, is generally constituted by a dispensing valve actuated by a dispensing head, the latter comprising a nozzle by means of which the aerosol composition is vaporized. The container containing the pressurized composition may be opaque or transparent. It can be made of glass, polymeric material or metal, possibly coated with a layer of protective enamel. The subject of the present invention is also a cosmetic process for treating human axillary odors, which consists in applying an effective amount of a composition as defined above to the axillary surface. The examples that follow serve to illustrate the present invention. 1 / Comparison of the deodorant activity of the zinc salicylate / aluminum salt association in relation to the associations of triclosan / aluminum salt and zinc ricinoleate / aluminum salt. Deodorant efficacy test protocol. sauna with 6 volunteers, samples of individual sweat, kept on ice for a few hours, are then practically odorless. Next, 1 ml aliquots were mixed and divided into aliquots. The active agents were added to these aliquots, then they were incubated in an oven at 37 ° C. After 24 hours of incubation, a jury of experts evaluated the odor intensity compared to a control sample: 1 ml of sweat incubated without active agent contribution. The intensity was evaluated on a scale of 0 (no odor) to 4 (very strong odor). The results are expressed in% variation of odor intensity compared to this sample of control sweat (mean of% variation at T24h). / - intensity odor intensity - odor intensity of the sample shows control with active agent? = x 100 intensity smell of the control sample ACH: Aluminum Chlorohydrate (Micro Dry - Reheis) (A): Zinc Salicylate (Bernardy Chimie) (B): Triclosan (CIBA) (C): Zinc Ricinoleate (Grillo Werke) It is observed that the zinc salicylate / aluminum salt (weight ratio: l / l) led to a synergy effect at the level of the decrease in odor intensity contrary to the Triclosan / aluminum salt and zinc ricinoleate / aluminum salt associations.

Example 1; Deodorant bar Cyclopentasiloxane was heated to 65 ° C. The other ingredients were added (1 by 1) remaining at 65-70 ° C. The whole (transparent solution) was homogenized for 15 minutes. The 2 deodorant active agents and the talc were added. It was refrigerated at about 55 ° C (a few degrees Celsius above the thickening of the mixture) and slipped into the bars. They were placed at 4 ° C for 30 minutes.

Example 2; Roll-on (emulsion) Phases (B) and (C) were heated separately at 70 ° C. Mixed (B) and (C) under Turax 5 mm agitation then cooled to 55 ° C under shovel. A was added gently under agitation. It was homogenized for 1 to 3 minutes. It was allowed to cool to 35 ° C under stirring. The formula is stable 2 months at 45 ° C.

Example 3; Non-aerosol spray (Emulsion obtained by phase inversion) The gluconate was solubilized in water and added to the Emulgade CM under moderate agitation. The aluminum salt solution was added under moderate agitation. The formula is stable 2 months at 45 ° C. It is noted that in relation to this date, the best method known to the applicant to carry out the aforementioned invention, is that which is clear from the present description of the invention.

Claims (32)

CLAIMS Having described the invention as above, the contents of the following claims are claimed as property:

1. Cosmetic deodorant composition, characterized in that it comprises at least: a) zinc salicylate or one of its derivatives, in free or hydrated form, - b) an anti-perspirant aluminum salt; oscillating the weight ratio zinc salicylate / aluminum salt between 1/500 and 10/1.

Composition according to claim 1, characterized in that the weight ratio of zinc salicylate / aluminum salt varies from 1/200 to 1/1.

Composition according to claim 1 or 2, characterized in that the antiperspirant salt is chosen from the aluminum halohydrates; the aluminum and zirconium halohydrates; complexes of zirconium hydroxychloride and aluminum hydroxychloride with an amino acid.

Composition according to claim 3, characterized in that the antiperspirant aluminum salt is selected from aluminum chlorohydrate in activated or non-activated form, aluminum hydrochloride, the complex of aluminum chlorhydrex polyethylene glycol, the complex of aluminum chlorhydrex propylene glycol, aluminum dihydrochloride, the aluminum complex dichlorhydrex polyethylene glycol, the aluminum complex dichlorhydrex propylene glycol, the aluminum sesquichlorhydrate, the aluminum complex sesquiclorhidrex polyethylene glycol, the aluminum complex sesquiclorhidrex propylene glycol, the aluminum sulfate aluminum buffered by sodium and aluminum lactate.

Composition according to claim 3, characterized in that the antiperspirant aluminum salt is chosen from aluminum zirconium octachloride, zirconium aluminum pentachloride, aluminum zirconium tetrachloride, aluminum zirconium trichlorohydrate.

6. Composition in accordance with the claim 3, characterized in that the antiperspirant aluminum salt is selected from the complexes of zirconium hydroxychloride and aluminum hydroxychloride with glycine.

Composition according to claim 6, characterized in that the antiperspirant aluminum salt is selected from aluminum complexes of zirconium octachlorhydrex glycine, zirconium aluminum pentachlorhydrex glycine, aluminum zirconium tetrachlorhydrex glycine and aluminum zirconium trichlorhydrex glycine.

8. Composition in accordance with any of the previous claims, characterized in that the antiperspirant aluminum salt is aluminum chlorohydrate in activated or non-activated form.

Composition according to any one of claims 1 to 8, characterized in that the antiperspirant aluminum salt or salts are present in amounts ranging from 0.5 to 25% by weight relative to the total weight of the composition.

10. Composition according to any of claims 1 to 9, characterized in that the zinc salicylate or one of its derivatives are selected from the following compounds of formula (1): wherein n = 2, p equals 0, 1, 2 or 3; R x denotes a linear or branched Ci-Cis alkyl; a hydroxyalkyl radical of Cx-Cie, linear or branched; a halogen atom; an acyl radical of C2-C ?3 a group COR2, OCOR2 or CONHR2 where R2 denotes a hydrogen atom or a straight or branched Cx-Cis alkyl radical.

11. Composition according to claim 10, characterized in that the compound of formula (I) is zinc salicylate (p = 0).

12. Composition according to claim 11, characterized in that the compound of formula (I) is zinc salicylate trihydrate.

13. Composition according to any of claims 1 to 12, characterized in that the concentration in zinc salicylate varies from 0.001 to 20%, preferably from 0.01 to 15% and also preferably from 0.05 to 15%. 5% by weight relative to the total weight of the composition.

14. Composition according to any of claims 1 to 13, characterized in that it is in the form of a lotion, cream or gel fluid distributed in an aerosol spray, in an atomizer or in a roll-on; in the form of a cream or gel distributed in a tube or in a grid; in the form of a bar (stick)

15. Composition according to any of the preceding claims, characterized in that it is different from an alcoholic aerosol composition.

16. Composition according to any of the preceding claims, characterized in that it comprises at least one aqueous phase.

Composition according to claim 16, characterized in that it is in the form of an aqueous lotion, in the form of a water-in-oil, oil-in-water emulsion; in the form of multiple emulsion.

18. Composition in accordance with claim 17, characterized in that the aqueous phase contains water and one or more solvents soluble or miscible in water.

Composition according to claim 18, characterized in that the solvents soluble or miscible in water are selected from the mono alcohols of C _.- C the diols; the polyols.

20. Composition according to any of claims 1 to 14, characterized in that it is anhydrous.

21. Composition according to any of claims 1 to 20, characterized in that it comprises at least one organic liquid phase not miscible with water.

22. Composition according to claim 21, characterized in that the organic liquid phase comprises one or more silicone or hydrocarbon emollient oils, volatile or non-volatile.

23. Composition according to claim 22, characterized in that the emollient oils are present in amounts ranging from 1 to 50% by weight and more preferably from 5 to 40% by weight relative to the total weight of the composition.

24. Composition according to any of claims 1 to 23, characterized in that it also comprises one or more additional deodorant active agents.

25. Composition in accordance with claim 24, characterized in that it also comprises one or more bacteriostatic agents or bactericidal agents.

26. Composition according to any of claims 1 to 25, characterized in that it also comprises one or more suspending agents.

Composition according to any of claims 1 to 26, characterized in that it also comprises at least one organic powder.

Composition according to any one of Claims 1 to 27, characterized in that it also comprises at least one cosmetic additive selected from waxes, softeners, antioxidants, opacifiers, stabilizers, moisturizing agents, vitamins, perfumes, bactericides, preservatives, polymers, perfumes, thickeners, propellants.

Composition according to any of claims 21 to 28, characterized in that it also comprises one or more structuring or gelling agents of the organic liquid phase not miscible with water.

30. Aerosol device, characterized in that it is constituted by: (A) a container comprising a deodorant composition according to any one of claims 1 to 29. (B) at least one propellant and a means of distributing said aerosol composition.

31. A cosmetic procedure for treating human axillary odors, characterized in that it consists in applying an effective amount of a composition according to any one of claims 1 to 29 to the axillary surface.

32. Use of the zinc salicylate or one of its derivatives and an antiperspirant aluminum salt according to any one of the preceding claims in a weight ratio zinc salicylate / aluminum salt ranging from 1/500 to 10/1, according to any one of the claims above as deodorant active agent in a cosmetic composition.